Related by context. All words. (Click for frequent words.) 76 Belimumab 73 Dapagliflozin 71 Mipomersen 71 Omacetaxine 71 proteasome inhibitor 71 KRN# 70 Dasatinib 70 Perifosine 70 Golimumab 70 Sapacitabine 70 Ofatumumab 70 Tesetaxel 70 Carfilzomib 70 angiogenesis inhibitor 70 Aliskiren 70 Archexin 70 Romidepsin 70 Talabostat 70 Arimoclomol 70 Muraglitazar 70 Maribavir 70 Pertuzumab 69 Ustekinumab 69 sodium glucose cotransporter 69 Cethromycin 69 Bortezomib 69 Vandetanib 69 Clevudine 69 Silodosin 69 Tanespimycin 69 Bavituximab 69 Vidofludimus 69 Ambrisentan 69 PDE4 inhibitor 69 nucleoside analog 69 Meets Primary Endpoint 69 Linaclotide 68 Methylnaltrexone 68 Blinatumomab 68 Hsp# Inhibitor 68 IMiDs ® 68 Voreloxin 68 multi kinase inhibitor 68 mertansine 68 vascular disrupting agent 68 Pazopanib 68 IMiDs R 68 Ridaforolimus 68 Cetrorelix 68 Temsirolimus 68 proteasome inhibitors 68 Lubiprostone 68 Aflibercept 68 selective serotonin 2C receptor 68 Pirfenidone 68 YONDELIS 68 MAGE A3 ASCI 68 TNF Tumor Necrosis Factor 68 sorafenib tablets 68 PEGylated Fab fragment 68 RhuDex ® 67 Cyclooxygenase Inhibiting Nitric Oxide 67 Laquinimod 67 MTP inhibitor 67 5 HT6 receptor 67 oral prodrug 67 immunotherapeutic agent 67 Deforolimus 67 Daclizumab 67 Naproxcinod 67 Ceflatonin 67 Tezampanel 67 Sym# 67 BYETTA ® 67 investigational humanized monoclonal antibody 67 Squalamine 67 injectable investigational 67 Nexavar ® 67 HQK 67 Bafetinib 67 Alogliptin 67 Icatibant 67 Crizotinib 67 Traficet EN 67 Tyrima 67 oral dihydropyrimidine dehydrogenase DPD 67 Phase 2b Clinical Trial 67 Nitazoxanide 67 Eltrombopag 67 Panzem R 67 selective kinase inhibitor 67 histone deacetylase HDAC inhibitor 67 renin inhibitor 67 CEQ# 67 Investigational Compound 67 MEK inhibitor 66 Omacetaxine mepesuccinate 66 Boceprevir 66 Darusentan 66 peripherally acting 66 Tolvaptan 66 targeting CD# 66 Epratuzumab 66 Dalbavancin 66 PKC# 66 INCB# [001] 66 Liprotamase 66 Novel Antibiotic 66 novel topoisomerase 66 Bucindolol 66 orally administered inhibitor 66 Apixaban 66 Febuxostat 66 protein tyrosine phosphatase 1B 66 MKC# MKC# PP 66 Onconase 66 BAY #-# 66 Anidulafungin 66 6R BH4 66 FOLOTYN ® 66 non peptidic protease 66 Sitagliptin 66 mitogen activated ERK kinase 66 Eculizumab 66 Pralatrexate 66 OMP #M# 66 Teriflunomide 66 potent topoisomerase II 66 BLyS specific 66 selective modulator 66 liposomal formulation 66 triggers apoptosis programmed 66 targeted radiotherapeutic 66 rilonacept 66 Romiplostim 66 highly selective inhibitor 66 Everolimus 66 Telavancin 66 MT#/MEDI-# 66 Phase 2a Clinical Trial 66 Adalimumab 66 Darinaparsin 66 Aptamer 66 pan HDAC inhibitor 66 Exenatide 66 Rivaroxaban 66 OMP #R# 66 Pemetrexed 66 Milnacipran 65 Elvitegravir 65 oral dual endothelin 65 receptor tyrosine kinase inhibitor 65 serotonin norepinephrine reuptake inhibitor 65 GW# [003] 65 acyclovir Lauriad R 65 mTOR inhibitor 65 investigational monoclonal antibody 65 Tarvacin TM 65 novel immunomodulatory 65 Pathway Inhibitor 65 CIMZIA TM 65 humanized monoclonal antibody 65 ZOLINZA 65 IMA# 65 PNP inhibitor 65 endothelin receptor antagonists 65 Raltegravir 65 Saxagliptin 65 orally bioavailable 65 Sudhir Agrawal D.Phil 65 PEGylated anti 65 Pixantrone 65 AAG geldanamycin analog 65 Aviptadil 65 CG# [003] 65 Phase 2a Study 65 Azedra 65 ATL# [001] 65 Fondaparinux 65 YONDELIS R 65 Mycophenolate Mofetil 65 Pivotal Phase III 65 torezolid phosphate 65 tezampanel 65 anti secretory 65 First Patient Dosed 65 small molecule thrombopoietin 65 diabetic neuropathic pain 65 HSP# inhibitor 65 Panzem R NCD 65 pralatrexate injection folate analogue 65 Irinotecan 65 immunomodulator 65 Anti VEGF 65 SRT# [003] 65 Trodusquemine MSI 65 HDAC Inhibitor 65 Phase III Clinical Trial 65 oral anticoagulant 65 Elagolix 65 vemurafenib 65 Bevacizumab 65 Clofarabine 65 chimeric monoclonal antibody 65 Ticagrelor 65 antibody MAb 65 GLYX 65 therapeutic monoclonal antibody 65 PEG SN# 65 PSN# [002] 65 riociguat 65 HuLuc# 65 Talactoferrin 65 oxidative stress inducer 65 PLK1 SNALP 65 HuMax EGFr 65 Phase IIb Trial 65 Serdaxin 65 vinca alkaloid 65 Aurora Kinase 65 Completes Patient Enrollment 65 Sphingomab 65 pseudobulbar affect PBA 65 Amrubicin 65 Ocrelizumab 65 Denufosol 65 Bosutinib 65 Actemra tocilizumab 65 Vernakalant 64 Noxafil 64 Degarelix 64 JAK Inhibitor 64 Initiates Phase III 64 oral proteasome inhibitor 64 Novel Mechanism 64 evaluating tivozanib 64 defensin mimetic antibiotic 64 LY# [003] 64 humanised monoclonal antibody 64 metaglidasen 64 Peginterferon alfa 2b 64 non nucleoside inhibitor 64 novel oral anticoagulant 64 CYT# potent vascular disrupting 64 Bezielle 64 fosbretabulin 64 SERMs 64 investigational oral 64 BAL# [002] 64 dasatinib Sprycel ® 64 ospemifene 64 Gefitinib 64 Aclidinium 64 Roflumilast 64 Zolinza 64 Tocilizumab 64 Trabectedin 64 MKC# 64 Seliciclib 64 Teplizumab 64 class mGluR5 inhibitor 64 Satraplatin 64 antiplatelet agent 64 SNT MC# 64 oral renin inhibitor 64 Fidaxomicin 64 vascular disrupting agents 64 Pafuramidine 64 humanized anti 64 Tumor Necrosis Factor 64 Tesamorelin 64 Receptor Agonist 64 selective estrogen receptor 64 Virulizin ® 64 Tyrosine Kinase Inhibitor 64 alefacept 64 AVE# 64 investigational oral inhibitor 64 JAK2 Inhibitor 64 xanthine oxidase inhibitor 64 GSK '# 64 PRTX 64 leading oral taxane 64 preclinically 64 depsipeptide 64 MKC# MT 64 Lacosamide 64 CCX# 64 phase III isavuconazole 64 Anti Tumor 64 BZL# 64 Clinical Trial Results 64 PSN# [001] 64 Initiates Clinical 64 radiation sensitizer 64 PDE# 64 EndoTAG TM -1 64 tolerated dose MTD 64 Zoraxel 64 Campath ® 64 BRILINTA 64 novel histone deacetylase 64 Fenofibrate 64 Olaparib 64 Lixisenatide 64 docetaxel Taxotere ® 64 IgG1 monoclonal antibody 64 AEG# 64 JAK2 inhibitor 64 Dabigatran etexilate 64 Aplidin 64 generation Hsp# inhibitor 64 Erlotinib 64 epothilones 64 direct thrombin inhibitors 64 Small Molecule 64 TACI Ig 64 methylnaltrexone bromide 64 angiotensin II receptor blocker 64 Bremelanotide 64 Elotuzumab 64 DORIBAX 64 investigational compound 64 novel peptide 64 MAP# 64 sorafenib Nexavar 64 Rigel R# 64 Nimotuzumab 64 ixabepilone 64 Angiocept 64 Gleevec resistant 64 PRT# 64 NXL# 64 PSMA ADC 64 erlotinib Tarceva ® 64 LymphoStat B 64 Preclinical Data 64 Alemtuzumab 64 Ceflatonin R 64 Tasimelteon 64 AMN# [001] 64 anti angiogenic agent 64 INCB# [003] 64 PEG Interferon lambda 64 DermaVir Patch 64 JAK inhibitor 64 selective inhibition 64 Pagoclone 64 mGluR5 NAM 64 Safinamide 64 GSK# [001] 64 Advanced Renal Cell 64 CCR9 antagonist 63 Vidaza azacitidine 63 GSK# [002] 63 Teriparatide 63 Phase 2a Trial 63 Ganciclovir 63 Tipranavir 63 Ataluren 63 polymerase inhibitor 63 HuMax CD# 63 Ipilimumab 63 renin inhibitors 63 insulin sensitizers 63 Rasagiline 63 Cetrorelix pamoate 63 ONGLYZA ™ 63 intranasal formulation 63 Prolongs Survival 63 albiglutide 63 IL# PE#QQR 63 Zalypsis 63 FDA Orphan Drug 63 Ixabepilone 63 tocilizumab 63 Telmisartan 63 Personalized Immunotherapy 63 LUVENIQ 63 Melphalan 63 5 HT3 antagonist 63 Pulmonary Arterial Hypertension 63 Sebivo 63 HuMax CD4 63 CYT# QbG# 63 ganetespib 63 TG# [003] 63 hyaluronidase enzyme 63 echinocandin 63 Gemcitabine 63 Factor Xa inhibitor 63 Annamycin 63 Fingolimod 63 Zarnestra 63 oral Janus kinase 63 Phase Ib II 63 Maraviroc 63 Enzastaurin 63 Interferon alpha 63 Phase IIb Clinical Trial 63 EZN 63 NS#/#A protease 63 delta opioid receptor 63 Bicifadine 63 Abiraterone acetate 63 Telaprevir 63 SPC# [001] 63 Decitabine 63 Investigational Drug 63 HCV protease inhibitors 63 MEK inhibitors 63 IAP inhibitors 63 peptidic compound 63 Antibody Drug Conjugate 63 Zoledronic acid 63 Obatoclax 63 Vicriviroc 63 pertuzumab 63 multitargeted 63 immune modulatory 63 IgG1 antibody 63 BRIM2 63 rNAPc2 63 Celebrex celecoxib 63 Granulocyte Colony Stimulating Factor 63 OvaRex R 63 GATTEX TM 63 Onalta 63 ThermoDox R 63 Exelixis XL# 63 Angiolix R 63 taxane derivative 63 adalimumab Humira 63 Adjuvant Treatment 63 DU #b 63 Glufosfamide 63 PD LID 63 Glatiramer Acetate 63 LymphoStat B TM 63 direct renin inhibitor 63 ELND# 63 atacicept 63 Antiangiogenic 63 thymalfasin 63 Rilonacept 63 Empatic TM 63 candidate deforolimus 63 Atiprimod 63 plasma kallikrein inhibitor 63 novel VDA molecule 63 thalidomide Thalomid 63 Mycamine 63 selective androgen receptor modulators 63 rxRNA 63 R#/MEM # 63 BiTE 63 rasagiline tablets 63 Aztreonam lysine 63 eltrombopag 63 Bevirimat 63 protein kinase inhibitor 63 Iloperidone 63 HCV protease 63 Serdaxin ® 63 modulator SERM 63 VitiGam 63 class anticancer quinolone 63 Orphan Status 63 SGLT Inhibitors 63 elotuzumab 63 Files IND 63 Fibrin Pad 63 Indaflex TM 63 SCH # 63 CA4P 63 small molecule glucokinase 63 thetreatment 63 Avanafil 63 Fulvestrant 63 Valsartan 63 Antitumor Activity 63 mild vasodilator 63 VA# [002] 63 Kuvan sapropterin dihydrochloride 63 antifungal agent 63 tubulin inhibitor 63 Granted Orphan Drug 63 fluoroquinolone antibiotic 63 Interferon Beta 63 Lomitapide 63 TMC# [002] 63 selective orally bioavailable 63 KNS # 63 octreotide acetate 63 Tofacitinib 63 OXi# 63 Varespladib 63 Nanobody 63 Investigational Treatment 63 dexpramipexole 63 Zenpep 63 oral antiviral 63 synthetic siRNA 63 Valdoxan 63 BCR ABL inhibitors 63 Kinase Inhibitor 63 Paliperidone Palmitate 63 anticancer agent 63 ApoB SNALP 63 Vilazodone 63 immunomodulating 63 Tasigna nilotinib 63 selective A2A adenosine receptor 63 Drug Candidate 63 seliciclib CYC# 63 Abatacept 63 Afatinib 63 Phase Ib IIa 63 CYP#A# CYP#D# 63 autologous cellular immunotherapy 63 Elacytarabine 63 ENMD # 63 Plasmin 63 TBC# 63 IMiDs ® compound 63 Cancidas 63 Milatuzumab 63 Ceftobiprole 63 Oracea TM 63 AEGR 63 Lung Cancer Drug 63 Cloretazine ® 62 relapsed leukemia 62 CYP#A# isoenzyme 62 Multiple Ascending Dose 62 Delafloxacin 62 PCK# 62 TYZEKA 62 Radezolid 62 icatibant 62 R sorafenib tablets 62 PEGylated interferon beta 1a 62 CBLC# 62 Panzem 62 Onco TCS 62 TRO# 62 docetaxel Taxotere R 62 guanfacine extended release 62 demonstrated antitumor activity 62 Initiates Enrollment 62 nanofiltered plasma derived 62 Aztreonam 62 Ramelteon 62 LHRH antagonist 62 Epidermal Growth Factor Receptor 62 phase IIb clinical 62 virus HCV protease inhibitor 62 Tarvacin 62 Crofelemer 62 small molecule Hedgehog 62 Ciclesonide 62 peptibody 62 topical gel formulation 62 midstage clinical 62 selective estrogen receptor modulator 62 intravenously administered 62 Friedreich Ataxia FRDA 62 ADP receptor antagonist 62 somatostatin analogue 62 systemic antifungal 62 Pimavanserin 62 Toremifene 62 lipoglycopeptide 62 targeted antifolate 62 echinocandins 62 Initiate Phase 62 AKT inhibitor 62 INSPIRE Trial Phase III 62 biologic therapy 62 Besivance 62 ZD# [001] 62 imatinib Gleevec ® 62 Oral Formulation 62 Proxinium TM 62 Cethrin R 62 generation purine nucleoside 62 HGS ETR1 62 inhalation powder 62 ALGRX 62 Lenalidomide 62 anti amnesic 62 anticancer compound 62 Fx #A 62 FDA Accepts 62 tumor vascular disrupting 62 Phase #b/#a clinical 62 IAP inhibitor 62 SUTENT ® 62 alkylating agent 62 huC# DM4 62 PROVENGE sipuleucel T 62 Diabetic Nephropathy 62 LHRH antagonists 62 NVA# 62 Orphan Drug 62 prodrug 62 Firazyr 62 REP# 62 Docetaxel 62 cathepsin K inhibitor 62 TAFA# 62 Xyrem ® 62 luteinizing hormone releasing 62 ISTODAX 62 Guanilib 62 compound INCB# 62 abatacept Orencia 62 indibulin 62 Nanobody ® 62 angiotensin receptor blocker ARB 62 Vicinium TM 62 microtubule inhibitor 62 insulin sensitizer 62 anticoagulant reversing agent 62 Combination REOLYSIN R 62 dihydrofolate reductase 62 PF # [002] 62 BENICAR HCT 62 hormone LHRH antagonist 62 melanocortin receptor agonists 62 Velcade bortezomib 62 Presents Preclinical Data 62 AP# [003] 62 vaccine RiVax TM 62 diarrhea predominant irritable 62 relapsed multiple myeloma 62 Unit Dose Budesonide 62 IMC A# 62 LY# [002] 62 JAK inhibitors 62 Genasense ® 62 Altabax 62 Phenoxodiol 62 BGC# 62 LymphoStat B belimumab 62 Bruton tyrosine kinase Btk 62 RECOTHROM R 62 forodesine 62 cilengitide 62 pathophysiological effects 62 Inhalation Aerosol 62 BioNumerik 62 dextromethorphan quinidine 62 EVIZON TM 62 Oral Fingolimod 62 specific lectin receptors 62 Alinia 62 nicotinic alpha 7 62 RAPAFLO 62 R lenalidomide 62 Imprime PGG 62 Factor VIIa 62 Factor Receptor 62 Xanafide 62 Trastuzumab 62 Hycamtin 62 ALN TTR 62 MEK Inhibitor 62 methylnaltrexone 62 Hedgehog Pathway Inhibitor 62 Cannabinor 62 Late Breaker 62 VAPRISOL 62 Anti TNF 62 oral isoform selective HDAC 62 antisense drug 62 herpetic keratitis 62 GTC recombinant human 62 sapacitabine CYC# 62 Fibrillex TM 62 selective androgen receptor modulator 62 RhuDex 62 Gamunex C 62 beta 1a 62 bevacizumab Avastin 62 Rifaximin 62 phase IIa clinical 62 sulodexide 62 potent inhibitor 62 long acting muscarinic 62 histone deacetylase HDAC inhibitors 62 Darunavir 62 Candesartan 62 Bazedoxifene 62 TRAIL R2 62 LEVADEX TM 62 Inhalation Solution 62 oral salmon calcitonin 62 factor Xa inhibitor 62 GLPG# 62 candidates Azedra 62 platform HDL Mimetic 62 Inhalation Powder 62 Curaxin 62 Therapeutic Vaccine 62 eprotirome 62 ZEVALIN ® 62 Phase III Clinical Trials 62 Pancreate 62 developing Zerenex ferric 62 ARRY # 62 GATTEX ® 62 Dacetuzumab 62 Homspera TM 62 Cloretazine VNP#M 62 alpha 2a 62 glucagon receptor 62 neuraminidase inhibitor 62 signal transduction inhibitor 62 candidate REP# 62 orally absorbed 62 vidofludimus 62 Albugon 62 IMC #B 62 Anticalin R 62 Lu AA# 62 M# rationally 62 RNAi Therapeutic 62 Previously Treated 62 ALVESCO R 62 synthetic anti infective 62 ZACTIMA 62 castrate resistant prostate cancer 62 regorafenib 62 Xcytrin R 62 bortezomib Velcade 62 Randomized Phase II 62 PI3K/Akt pathway inhibitor 62 Chemokine Receptor 62 adenosine injection 62 Prospective Randomized 62 somatostatin analog 61 Montelukast 61 TRX1 61 Amplimexon 61 Randomized Phase 61 Civacir 61 Alfacell proprietary ribonuclease 61 Tarceva TM 61 Anacetrapib 61 R roscovitine 61 ThGRF 61 Rosuvastatin 61 IRX 2 61 Palonosetron 61 Alvesco R 61 SAR# [004] 61 Sorafenib Nexavar 61 TLR9 agonist 61 canakinumab 61 Ecallantide 61 PROCHYMAL 61 histone deacetylase inhibitor 61 OncoVEX GM CSF 61 Rebif ® 61 Aganocide ® 61 Myelodysplastic Syndrome MDS 61 SAR# [002] 61 Cutaneous T 61 nalbuphine ER 61 BiTE R 61 Hormone Refractory Prostate Cancer 61 mTOR mammalian target 61 Well Tolerated 61 NEUGENE 61 Medidur TM FA 61 Zerenex 61 Prodarsan R 61 Cloretazine 61 Clolar ® 61 pomalidomide 61 TLK# 61 PHX# 61 Toctino ® alitretinoin 61 Chemophase 61 ZALBIN 61 novel orally bioavailable 61 Vildagliptin 61 Certican 61 immunomodulatory 61 Sorafenib 61 Pramlintide 61 nucleoside reverse transcriptase inhibitor 61 ALS #-# 61 mapatumumab 61 Prodrug 61 #D#C# 61 Afferent Pharmaceuticals 61 Monoclonal Antibody 61 tigecycline 61 SNRI 61 CGEN # 61 Azixa 61 radezolid 61 Single Dose 61 trodusquemine 61 accumulate preferentially 61 Prodarsan ® 61 stable nucleic acid 61 ALN PCS 61 Humanized Anti 61 II Clinical Trial 61 CCR5 mAb 61 familial amyloidotic polyneuropathy FAP 61 apoptosis inducer 61 ofatumumab HuMax CD# 61 CRMD# 61 DP b# 61 Cathepsin S 61 histone deacetylase inhibitors 61 Brentuximab vedotin 61 ATL/TV# 61 ISENTRESS 61 CRD5 61 Microplasmin 61 Aplidin R 61 Azacitidine 61 Zingo TM 61 Cand5 61 MDV# 61 developing Bicifadine serotonin 61 lumiliximab 61 SGLT2 inhibitor 61 NeuroSTAT ® 61 Lisofylline LSF 61 MGd 61 Synerx Pharma 61 Nalmefene 61 Anavex #-# 61 myelofibrosis polycythemia vera 61 telomerase therapeutic 61 Immunotherapeutic 61 EMBEDA ™ 61 reversible inhibitors 61 small molecule chemotherapeutic 61 Phase 2b Trial 61 posaconazole 61 Epothilones 61 anticancer agents 61 Oral Insulin 61 volociximab 61 Levofloxacin 61 2 methoxyestradiol 61 GFT# 61 Abstral ® 61 sunitinib Sutent ® 61 oncolytic vaccine 61 Solulin 61 Initiates Phase II 61 lead Aganocide compound 61 atrasentan 61 masitinib 61 delafloxacin 61 CK # novel 61 Liraglutide 61 Forodesine HCl 61 PDX pralatrexate 61 HCl Injection 61 selective inhibitor 61 MORAb 61 Phase 1b Clinical Trial 61 Aztreonam Lysine 61 bevacizumab Avastin ® 61 Panitumumab 61 Cyclooxygenase 2 61 NPC 1C 61 Horizant ™ 61 intravitreal insert 61 Angiolix 61 topically applied SEPA 61 Alfimeprase 61 Aurora kinase 61 PrevOnco 61 Orally administered 61 Tumour Vascular Disrupting Agent 61 Valproic acid 61 OvaRex ® MAb 61 Entecavir 61 Fodosine 61 anticancer activity 61 PDE4 61 Yondelis ® 61 Triphendiol 61 OMNARIS HFA 61 ketolide antibiotic 61 motexafin gadolinium Injection 61 Erbitux cetuximab 61 hormone agonist 61 CD# monoclonal antibody 61 HCD# [002] 61 sitaxsentan 61 Calcitonin 61 alvespimycin 61 TEMODAL 61 Rotigotine 61 cytostatic 61 Hematide ™ 61 cediranib 61 Troxatyl 61 Cardio Vascu Grow 61 Metastatic Melanoma 61 SPRIX ® 61 #ME# 61 aripiprazole Abilify 61 GMX# 61 metastatic colorectal 61 investigational drug 61 GRN# 61 interferon gamma 1b 61 humanized monoclonal 61 novel orally administered 61 TPI ASM8 61 Prostate AdenoCarcinoma Treatment 61 Iluvien ® 61 Pegloticase 61 Angiotensin Converting Enzyme 61 Tarmogen 61 reslizumab 61 sunitinib malate 61 MGCD# [001] 61 AVONEX ® 61 DACH platinum 61 bortezomib Velcade R 61 agonistic human 61 hypoxia activated prodrug 61 IMPDH inhibitor 61 Anticancer Agent 61 visilizumab 61 PGL# 61 A3 adenosine receptor 61 XYOTAX TM 61 HCV Protease Inhibitor 61 CCR5 antagonist 61 SYN# 61 Vitrasert R 61 Intranasal 61 anti leukemic 61 neuroprotectant 61 Apaziquone 61 highly selective endothelin 61 Oxaliplatin 61 LibiGel ® 61 Gemzar ® 61 Emollient Foam 61 oral anticancer 61 EOquin 61 Ixempra 61 investigational pan BCR 61 Palifosfamide 61 Indomethacin 61 Gout Drug 61 Viprovex TM 61 Renal Cell Carcinoma 61 canagliflozin 61 relapsed MM 61 Allovectin 7 61 Extended Release 61 Omnitarg 61 mecamylamine 61 topical ophthalmic 61 Eraxis 61 MabCampath 61 eniluracil 61 erythropoiesis stimulating agent 61 HCV protease inhibitor 61 Certolizumab pegol 61 Zybrestat 61 selective antagonist 61 topical antifungal 61 CR# vcMMAE 61 Phase 2b Study 61 Zysolin TM 61 inhibitor PPI 61 Oral Spray 61 etanercept Enbrel 61 #HT# 61 CINQUIL 61 Zoraxel TM 61 R bortezomib 61 label Lipofen R 61 AFREZZA TM 61 autologous cellular immunotherapies 61 Receives Orphan Drug Designation 61 Kevetrin ™ 61 XL# XL# 61 Phenoptin 61 Cabazitaxel 61 Keryx Biopharma 61 ALN HPN